These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 3106478

  • 1. Reversal of advanced murine lupus in NZB/NZW F1 mice by treatment with monoclonal antibody to L3T4.
    Wofsy D, Seaman WE.
    J Immunol; 1987 May 15; 138(10):3247-53. PubMed ID: 3106478
    [Abstract] [Full Text] [Related]

  • 2. Administration of monoclonal anti-T cell antibodies retards murine lupus in BXSB mice.
    Wofsy D.
    J Immunol; 1986 Jun 15; 136(12):4554-60. PubMed ID: 3086436
    [Abstract] [Full Text] [Related]

  • 3. Proliferation of Ly-1 B cells in autoimmune NZB and (NZB x NZW)F1 mice.
    Wofsy D, Chiang NY.
    Eur J Immunol; 1987 Jun 15; 17(6):809-14. PubMed ID: 2954827
    [Abstract] [Full Text] [Related]

  • 4. Treatment of murine lupus with F(ab')2 fragments of monoclonal antibody to L3T4. Suppression of autoimmunity does not depend on T helper cell depletion.
    Carteron NL, Schimenti CL, Wofsy D.
    J Immunol; 1989 Mar 01; 142(5):1470-5. PubMed ID: 2521880
    [Abstract] [Full Text] [Related]

  • 5. Treatment of murine lupus with monoclonal antibody to L3T4. II. Effects on immunohistopathology of thymus, spleen, and lymph node.
    Ermak TH, Steger HJ, Wofsy D.
    Lab Invest; 1989 Oct 01; 61(4):447-56. PubMed ID: 2529396
    [Abstract] [Full Text] [Related]

  • 6. Class-specific regulation of anti-DNA antibody synthesis and the age-associated changes in (NZB x NZW)F1 hybrid mice.
    Sekigawa I, Okada T, Noguchi K, Ueda G, Hirose S, Sato H, Shirai T.
    J Immunol; 1987 May 01; 138(9):2890-5. PubMed ID: 2952727
    [Abstract] [Full Text] [Related]

  • 7. Autoimmune syndrome after induction of neonatal tolerance to alloantigens: effects of in vivo treatment with anti-T cell subset monoclonal antibodies.
    Merino J, Schurmans S, Luzuy S, Izui S, Vassalli P, Lambert PH.
    J Immunol; 1987 Sep 01; 139(5):1426-31. PubMed ID: 3114366
    [Abstract] [Full Text] [Related]

  • 8. Development of murine lupus in CD4-depleted NZB/NZW mice. Sustained inhibition of residual CD4+ T cells is required to suppress autoimmunity.
    Connolly K, Roubinian JR, Wofsy D.
    J Immunol; 1992 Nov 01; 149(9):3083-8. PubMed ID: 1357036
    [Abstract] [Full Text] [Related]

  • 9. Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.
    Wofsy D, Seaman WE.
    J Exp Med; 1985 Feb 01; 161(2):378-91. PubMed ID: 3919141
    [Abstract] [Full Text] [Related]

  • 10. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
    Merino R, Iwamoto M, Fossati L, Izui S.
    J Immunol; 1993 Dec 01; 151(11):6509-16. PubMed ID: 7902378
    [Abstract] [Full Text] [Related]

  • 11. Animal models utilized in the research of autoimmune disease control: experimental therapy of glomerulonephritis in NZB/W F1 mice.
    Okudaira H, Terada E, Okudaira K.
    Prog Clin Biol Res; 1987 Dec 01; 229():157-74. PubMed ID: 3601985
    [Abstract] [Full Text] [Related]

  • 12. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
    Liang B, Gardner DB, Griswold DE, Bugelski PJ, Song XY.
    Immunology; 2006 Nov 01; 119(3):296-305. PubMed ID: 17067309
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of T and B cell collaboration in the in vitro production of anti-DNA antibodies in the NZB/NZW F1 murine SLE model.
    Ando DG, Sercarz EE, Hahn BH.
    J Immunol; 1987 May 15; 138(10):3185-90. PubMed ID: 2952711
    [Abstract] [Full Text] [Related]

  • 14. Interleukin 6 promotes murine lupus in NZB/NZW F1 mice.
    Finck BK, Chan B, Wofsy D.
    J Clin Invest; 1994 Aug 15; 94(2):585-91. PubMed ID: 8040314
    [Abstract] [Full Text] [Related]

  • 15. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response.
    Early GS, Zhao W, Burns CM.
    J Immunol; 1996 Oct 01; 157(7):3159-64. PubMed ID: 8816428
    [Abstract] [Full Text] [Related]

  • 16. Treatment of murine lupus with monoclonal antibody to L3T4. I. Effects on the distribution and function of lymphocyte subsets and on the histopathology of autoimmune disease.
    Wofsy D, Chiang NY, Greenspan JS, Ermak TH.
    J Autoimmun; 1988 Oct 01; 1(5):415-31. PubMed ID: 3267085
    [Abstract] [Full Text] [Related]

  • 17. Defects in the regulation of anti-DNA antibody production in aged lupus-prone (NZB x NZW)F1 mice: analysis of T-cell lymphokine synthesis.
    Sato MN, Minoprio P, Avrameas S, Ternynck T.
    Immunology; 1995 May 01; 85(1):26-32. PubMed ID: 7635519
    [Abstract] [Full Text] [Related]

  • 18. Cellular basis of in vitro anti-DNA antibody production: evidence for T cell dependence of IgG-class anti-DNA antibody synthesis in the (NZB X NZW)F1 hybrid.
    Sekigawa I, Ishida Y, Hirose S, Sato H, Shirai T.
    J Immunol; 1986 Feb 15; 136(4):1247-52. PubMed ID: 3484766
    [Abstract] [Full Text] [Related]

  • 19. Genetic control of the spontaneous activation of CD4+ Th cells in systemic lupus erythematosus-prone (NZB x NZW) F1 mice.
    Fujii T, Iida Y, Yomogida M, Ikeda K, Haga T, Jikumaru Y, Ninami M, Nishimura N, Kodera Y, Inada Y, Shirai T, Hirose S, Nishimura H.
    Genes Immun; 2006 Dec 15; 7(8):647-54. PubMed ID: 17024131
    [Abstract] [Full Text] [Related]

  • 20. Treatment of lupus in NZB/W F1 mice with monoclonal antibody against Fas ligand.
    Nakajima A, Hirai H, Kayagaki N, Yoshino S, Hirose S, Yagita H, Okumura K.
    J Autoimmun; 2000 Mar 15; 14(2):151-7. PubMed ID: 10677246
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.